(Q35789508)

10 August 2017

1 reference

title

Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease (English)

1 reference

10 August 2017

1 reference

Frithjof Blessing

1

1 reference

10 August 2017

Ying Wang

series ordinal

2

1 reference

10 August 2017

Autar K Walli

series ordinal

3

1 reference

10 August 2017

Dietrich Seidel

series ordinal

4

1 reference

10 August 2017

publication date

1 June 2004

1 reference

Transfusion and Apheresis Science

10 August 2017

published in

1 reference

10 August 2017

volume

30

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

255-266

1 reference

A new approach to the management of familial hypercholesterolaemia: Removal of plasma-cholesterol based on the principle of affinity chromatography

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Complement activation and depletion during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation (HELP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Hyperlipoprotein(a)aemia in nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Influence of serum lipids on auditory function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Atherosclerosis and hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Changes in oxidative stress and microcirculation by low-density lipoprotein apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Blood purification therapies using dextran sulfate cellulose columns Liposorber and Selesorb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Improvements in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Fibrinogen and peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Effects of ameliorated haemorheology on clinical symptoms in cerebrovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.009

10.1016/J.TRANSCI.2004.01.009

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference